Streetbeat News

Stock Prices

CNQ

Canadian Natural Res (NYSE:CNQ) has outperformed the market over the past 20 years, producing an average annual return of 13.52%. If an investor had bought $100 of CNQ stock 20 years ago, it would be worth $1,273.54 today.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 3:30 pm

TRGP

Targa Resources reported its Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 3:28 pm

BMY

Daiwa Capital analyst Narumi Nakagiri has downgraded Bristol-Myers Squibb (NYSE:BMY) from Outperform to Neutral and lowered the price target from $68 to $54.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 3:28 pm

WES

Western Midstream Partners reported better-than-expected Q3 EPS results and issued strong FY23 adjusted EBITDA guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 3:27 pm

TOL

In the last quarter, Toll Brothers (NYSE:TOL) received various analyst ratings, with a total of 4 bullish, 4 somewhat bullish, 3 indifferent, 2 somewhat bearish, and 1 bearish. The average price target for TOL is $88.14, indicating an upside from the current price of $78.26. This average price target has increased by 7.23% over the past month.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 3:27 pm

OSCR

In the last quarter, Oscar Health (NYSE:OSCR) received mixed analyst ratings with 1 bullish, 1 somewhat bullish, and 2 indifferent. Over the past 3 months, 4 analysts have offered 12-month price targets for Oscar Health, with an average price target of $8.12, up by 27.27% from the previous average price target of $6.38.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 3:27 pm

EIX

Edison Intl (NYSE:EIX) has received mixed analyst ratings in the last quarter, with 1 bullish, 3 somewhat bullish, 3 indifferent, and 3 somewhat bearish. Over the past 3 months, 10 analysts have offered 12-month price targets for Edison Intl, with an average price target of $67.1, a decrease of 0.22% from the previous average price target of $67.25.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 3:27 pm

BALY

Analysts have provided mixed ratings for Ballys (NYSE:BALY) in the last quarter, with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for Ballys is $16.5, a decrease of 23.26% from the previous average price target of $21.50.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 3:27 pm

APLS

Over the past 3 months, 21 analysts have published their opinion on Apellis Pharmaceuticals (NASDAQ:APLS) stock. The analysts have an average price target of $65.0 versus the current price of Apellis Pharmaceuticals at $51.075, implying an upside. This current average has increased by 16.42% from the previous average price target of $55.83.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 3:26 pm

AMD

Over the past 3 months, 8 analysts have published their opinion on Advanced Micro Devices (NASDAQ:AMD) stock. The average price target is $125.75, representing a 12.98% decrease from the previous average price target of $144.50. The ratings are generally bullish.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 3:26 pm